P11-13 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 2001-10-17
著者
-
Akaike Masashi
Japan Pharmaceutical Manufactures Association
-
SHIMIZU KENJI
Japan Pharmaceutical Manufacturers Association
-
MATSUZAWA TOSHIAKI
Japan Pharmaceutical Manufacturers Association
-
Taniguchi Katsuhiko
Japan Pharmaceutical Manufacturers Association
-
Nishimura Chihiro
Japan Pharmaceutical Manufactures Association
-
Moriyama Tomoyuki
Japan Pharmaceutical Manufactures Association
-
Maeda Yasuyuki
Japan Pharmaceutical Manufactures Association
-
Kuse Hiroshi
Japan Pharmaceutical Manufactures Association
-
Matsuzawa Toshiaki
Japan Pharmaceutical Manufactures Association
-
NISHIDA Nobuyuki
Japan Pharmaceutical Manufactures Association
-
Shimizu Kenji
Japan Pharmaceutical Manufactures Association
-
Taniguchi Katsuhiko
Japan Pharmaceutical Manufactures Association
関連論文
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 2) : Point of GLP (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Survey of Carcinogenicity Studies of the Pharmaceuticals in Rodents
- A Comparision of the Results of Rat and Mouse Carcinogenicity Studies Conducted on Pharmaceuticals
- Questionnaire survey on cardiac electrophysiology examination in safety pharmacology studies.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)
- 3B-14 A Survey of Statistical Analysis Methods of Numerical Data in Repeated Dose Toxicity Studies in Europe and U.S.
- Survey of pharmacology study conduct using outside sources in pharmaceutical companies in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Study Monitor : The Surveillance of Outsourced Non-Clinical Studies : Draft Report, Final Report, Archives, and Quality Assurance(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CUR
- Study monitor : the Surveillance of Outsourced Non-Clinical Studies (Reproductive Studies,Pathology and Toxicokinetics).(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURV
- Study Monitor. The Surveillance of Outsourced Non-Clinical Studies : Testing facility checking, Protocol, Formulation and In-life phase(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STU
- Study Monitor. Introduction of the Surveillance for Outsourcing Non-Clinical Studies and Summary of Toxicology.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Summary of Questionnaire Surveys of Toxicokinetics in Pharmaceutical Industries in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : STRATEGIC TOXICOKINETICS ON DRUG DISCOVERY(CURRENT SURVEY))
- Responsibility of Monitor for Quality Assurance of Outsourcing Non-clinical Studies.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- P11-13 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- P11-12 Questionnaire Survey of Functional Observational Battery in Pharmaceutical Industries in Japan.
- O10-18 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- The Ideal Vision for the Single Dose Toxicity Study in Non-rodents.(GENERAL SESSION BY ORAL PRESENTATION)(CONSIDERATION OF SINGLE DOSE TOXICITY STUDY IN NON-RODENTS(CURRENT SURVEY))